Market closed

Rani Therapeutics/$RANI

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Rani Therapeutics

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

Ticker

$RANI
Trading on

Industry

Pharmaceuticals

Employees

140

RANI Metrics

BasicAdvanced
$62M
Market cap
-
P/E ratio
-$1.05
EPS
0.11
Beta
-
Dividend rate
$62M
0.11
$8.75
$1.85
517K
1.602
1.504
303.965
584.104
-9.95%
-56.80%
-270.57%
17.77
17.77
-1.254
-25.45%
87.59%

What the Analysts think about RANI

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Rani Therapeutics stock.

RANI Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

RANI Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $RANI

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Rani Therapeutics stock?

Rani Therapeutics (RANI) has a market cap of $62M as of December 13, 2024.

What is the P/E ratio for Rani Therapeutics stock?

The price to earnings (P/E) ratio for Rani Therapeutics (RANI) stock is 0 as of December 13, 2024.

Does Rani Therapeutics stock pay dividends?

No, Rani Therapeutics (RANI) stock does not pay dividends to its shareholders as of December 13, 2024.

When is the next Rani Therapeutics dividend payment date?

Rani Therapeutics (RANI) stock does not pay dividends to its shareholders.

What is the beta indicator for Rani Therapeutics?

Rani Therapeutics (RANI) has a beta rating of 0.11. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.